Skip to main content

GSA CAPITAL PARTNERS LLP

Position in EWTX — Edgewise Therapeutics, Inc.

CIK 1362033 LONDON, X0

Position in EWTX

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$1,806,653
+$1,457,134 QoQ
Shares Held
44,466
+215.7% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#95
of 223 holders
Holding Since
Jun 2022
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EWTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $104,909,103 across 164 Biotechnology names. EWTX ranks #12 (1.7% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in EWTX

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,806,653 44,466
2025-12-31 $349,519 14,085
2025-09-30 $1,836,801 113,243
2025-06-30 $357,588 27,276
2024-12-31 $309,533 11,593
2024-03-31 $1,359,080 74,511
2023-12-31 $576,100 52,660
2023-09-30 $251,913 43,964
2022-12-31 $235,720 26,367
2022-09-30 $269,497 27,388
2022-06-30 $137,803 17,312